Post

A more than 40% risk reduction “would send many researchers over the Moon”. This personalised mRNA vaccine reduced the risk of skin cancer returning or the recipient dying by 42% go.nature.com/4BCB7k6

go.nature.comModerna mRNA vaccine almost halves the risk of skin cancer returningLong-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.

23/10/26, 11:51 am34 reposts100 likes

johnmneu.bsky.social

@johnmneu.bsky.social

www.cnbc.com/2026/10/22/m...

cnbc.comModerna shares plunge after cancer vaccine data leaks — despite positive resultsModerna released full data on its closely watched cancer vaccine developed with Merck.